OptimizeRx (OPRX) Short term Debt (2023 - 2026)

OptimizeRx (OPRX) has 4 years of Short term Debt data on file, last reported at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt fell 39.39% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 39.39% YoY), and the FY2025 full-year result was $4.3 million, up 112.75% from the prior year.
• Short term Debt slipped to $2.0 million in Q1 2026, from $4.3 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.3 million in Q4 2025 to a low of $2.0 million in Q4 2023.
• A 4-year average of $2.9 million and a median of $3.3 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt jumped 112.75% in 2025 and slumped 39.39% in 2026, its largest moves.
• Tracing OPRX's Short term Debt over 4 years: stood at $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then jumped by 112.75% to $4.3 million in 2025, then sank by 53.0% to $2.0 million in 2026.
• Business Quant data shows OPRX's Short term Debt at $2.0 million in Q1 2026, $4.3 million in Q4 2025, and $3.3 million in Q3 2025.